Gardner Lewis Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-22,856
Closed -$3.81M 107
2016
Q3
$3.81M Buy
22,856
+3,000
+15% +$507K 0.31% 46
2016
Q2
$3.02M Buy
19,856
+5,515
+38% +$857K 0.32% 58
2016
Q1
$2.15M Buy
14,341
+3,846
+37% +$571K 0.42% 50
2015
Q4
$1.7M Buy
+10,495
New +$1.65M 0.27% 63
2014
Q1
Sell
-8,222
Closed -$938K 88
2013
Q4
$938K Buy
+8,222
New +$935K 0.32% 72

Other funds holding AMGN

Gardner Lewis Asset Management's AMGN Position: Q4 2016 in Review

Gardner Lewis Asset Management sold out of Amgen (AMGN) in Q4 2016, closing a stake of 22,856 shares — an estimated $3.81M sold.

Gardner Lewis Asset Management first reported a position in AMGN in Q4 2013 and held it in 5 quarters. The position peaked at $3.81M in Q3 2016. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • Gardner Lewis Asset Management reported no remaining Amgen position as of Q4 2016 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 22,856 Amgen shares in Q4 2016, an estimated $3.81M.
  • Gardner Lewis Asset Management first reported a position in Amgen in Q4 2013 and held it in 5 quarters.
  • Gardner Lewis Asset Management's Amgen position peaked at $3.81M in Q3 2016.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.